147767-51-9

Basic information

• Product Name: 4-benzyl-2-cyanomorpholine
• CAS NO: 147767-51-9
• Molecular Weight: 202.256
• Mol File: 147767-51-9.mol
• Article Data: 26

Chemical Properties

• CAS DataBase Reference: 4-benzyl-2-cyanomorpholine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-benzyl-2-cyanomorpholine(147767-51-9)
• EPA Substance Registry System: 4-benzyl-2-cyanomorpholine(147767-51-9)

Safety Data

• Hazardous Substances Data: 147767-51-9(Hazardous Substances Data)

Upstream product

• 107-14-2 chloroacetonitrile 
• 104-63-2 N-Benzylethanolamine 
• 110859-47-7 (4-benzylmorpholin-2-yl)methanamine 
• 920-37-6 2-Chloroacrylonitrile 
• 1030837-46-7 3-(benzyl(2-hydroxyethyl)amino)-2-chloro-propanenitrile 

Downstream Products

• 135072-32-1 ethyl 4-benzylmorpholine-2-carboxylate 
• 667876-55-3 (+/-)-[4-methoxyphenyl(4-benzylmorpholin-2-yl)]methanone 
• 521969-46-0 (4-benzyl-morpholin-2-yl)-phenylmethanone 
• 1357565-82-2 1-(4-benzylmorpholin-2-yl)-2-(2-phenylphenyl)-ethanone 
• 1357565-83-3 2-(4-benzyl-morpholin-2-yl)-1,1,1-trifluoro-3-phenylpropan-2-ol 
• 1357565-84-4 2-(4-benzyl-morpholin-2-yl)-1,1,1-trifluoro-3-(2-methoxyphenyl)-propan-2-ol 
• 1357565-87-7 benzyl 2-(1-benzyl-2,2,2-trifluoro-1-hydroxyethyl)morpholine-4-carboxylate 
• 1357565-88-8 benzyl 2-(1-(2-methoxyphenyl)methyl-2,2,2-trifluoro-1-hydroxyethyl)morpholine-4-carboxylate 
• 1357565-73-1 1,1,1-trifluoro-2-morpholin-2-yl-3-phenylpropan-2-ol hydrochloride 
• 1357565-74-2 1,1,1-trifluoro-3-(2-methoxyphenyl)-2-(morpholin-2-yl)-propan-2-ol hydrochloride 
• 1357565-81-1 1-(4-benzylmorpholin-2-yl)-2-phenylethanone 
• 885096-37-7 1-(4-benzylmorpholin-2-yl)-2-(2-methoxyphenyl)-ethanone 
• 126645-58-7 N-(4-Benzyl-morpholin-2-ylmethyl)-3,5-dichloro-4-dimethylamino-2-hydroxy-benzamide 
• 126645-62-3 N-(4-Benzyl-morpholin-2-ylmethyl)-3,4,5-trimethoxy-benzamide 

Relevant articles and documents

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).

SUBSTITUTED [1,2,4] TRIAZOLO [1,5-A] PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS

The invention provides a chemical entity of Formula (I): wherein R1, R2, X, Y and Z have any of the values described herein, and compositions comprising such chemical entities; methods of making them; and their use in a wide range of

DIHYDROPTERIDINONE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF

Dihydroperidinone derivatives, preparation process and pharmaceutical use thereof are disclosed. Specially, new dihydroperidinone derivatives represented by general formula (I), wherein each substituent of the general formula (I) is defined as in the description, their preparation process, pharmaceutical compositions comprising said derivatives and their use as therapeutical agents, especially as Plk kinase inhibitors are disclosed.